Status:
COMPLETED
Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects
Lead Sponsor:
Allergan
Conditions:
Eyelash Hypotrichosis
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This study will evaluate the safety and efficacy of LATISSE® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women.
Eligibility Criteria
Inclusion
- Eyelash prominence assessment of minimal or moderate
- Of Korean ethnicity
Exclusion
- Any eye disease or abnormality
- Any ocular surgery or use of any eyelash extension or eyelash growth products within 3 months
- Any permanent eyeliner within 5 years
- Eyelash implants of any kind
- Eyelash tint or dye application within 2 months
- Use of any treatment that may affect hair growth within 6 months
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT01229423
Start Date
November 1 2009
End Date
October 1 2010
Last Update
January 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul, South Korea